These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2028528)

  • 1. [Quality of life with adjuvant treatment of breast cancer].
    Grønvold M
    Ugeskr Laeger; 1991 Apr; 153(17):1185-9. PubMed ID: 2028528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quality of life in relation to patient education regarding surgical procedures in primary breast carcinoma].
    Gerber B; Krause A
    Zentralbl Gynakol; 1997; 119(4):149-53. PubMed ID: 9206919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant radiotherapy of breast carcinoma].
    Seegenschmiedt MH; Sauer R; Strnad V
    Praxis (Bern 1994); 1995 Mar; 84(13):377-85. PubMed ID: 7709118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Locoregional radiotherapy after mastectomy and chemotherapy for breast cancer: prolonged survival and better local tumor control].
    Struikmans H; van Tienhoven G; Jobsen JJ; Jager JJ; Borger JH; Scheijmans LJ
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):71-3. PubMed ID: 10086106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy in breast cancer: status in 1984].
    Jungi WF
    Wien Klin Wochenschr; 1984 Jun; 96(13):486-92. PubMed ID: 6382805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative radiotherapy treatment of early breast cancer].
    Overgaard M; Kvistgaard ME; Thomsen MS
    Ugeskr Laeger; 2007 Sep; 169(36):2993-6. PubMed ID: 17953879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors increasing local recurrence in breast-conserving surgery.
    Fatouros M; Roukos DH; Arampatzis I; Sotiriadis A; Paraskevaidis E; Kappas AM
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):737-45. PubMed ID: 16111473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
    Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necessity of adjuvant therapy after radical mastectomy based on a study of patients with negative nodes, who have recurrent breast cancer].
    Asagoe T; Yamoto H; Nemoto A; Shikata J; Aoki A; Nakayama R; Tashiro Y
    Gan No Rinsho; 1988 Jan; 34(1):41-4. PubMed ID: 3339848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance].
    Gundersen S; Bøhler P; Hannisdal E; Høst H
    Tidsskr Nor Laegeforen; 1996 Jan; 116(2):222-5. PubMed ID: 8633328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.